The New Face of Business Activism

     On March 9th, I accurately predicted an AbbVie Inc. (ABBV) market low in my blog, "AbbVie (ABBV): Its Now Time to Get In".  This was about the lowest the stock got since October of last year.  The stock went from $55.64 to close at $66.07, yesterday, just 46 days later--generating an 18.7% gain.

While I realize that there are many people and events that have influenced AbbVie's climb, I maintain that I was one of the individual players involved.  I wrote three, very high quality blogs in March that I believe helped persuade investors.  They can be found at my blog: American Galileo.  The following is a summary:

(1) "Pay your own way for a better life."  In this personal, historical narrative, I explored a life that chose to stand by one's own economic productivity despite financial pressure.  I showed the pride involved and ultimate triumph.

(2) "Socialist Takeover of Pharmaceutical Companies' Prices?"  This blog defended property rights--specifically, the freedom of trade.  I exposed the behavior of Express Scripts and appealed to the moral solution--that being to "...give up the economically devastating dream of free lunches without capitalist payment".

(3) "A Promise Kept?  A Lie Made."  In this blog, I took on medical "entitlements" in a way that differed from the traditional, Objectivist approach.  I argued that there shouldn't even be a "sliding scale" reduction, and that all of the socialist programs are already, completely gone.

While there have been some people doing this, I envision a new career field that integrates my kind of blogging with a deeply, philosophical level of business activism.  As an intellectual, I seek to team-up with the businessman in an alliance where my thought generates his profit, and his products improve my mind.  Of course, it also helps that I make money directly from my market activities, as I am doing.

Paul Wharton
Objectivist Capitalist Medicine Promoter